sales@marketresearchvision.com

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports


Global Remicade Biosimilar Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Remicade Biosimilar Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Category : Pharmaceuticals and Healthcare QY Research Pages :117
Published Date : 2020-12-15

 

Covid-19

COVID-19

Understand the influence of COVID-19 on the Remicade Biosimilar Market with our analysts monitoring the situation across the globe.
Remicade Biosimilar market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Remicade Biosimilar market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026. Segment by Type, the Remicade Biosimilar market is segmented into 100mg/10ml 500mg/50ml Segment by Application, the Remicade Biosimilar market is segmented into Blood Disorders Oncology Diseases Regional and Country-level Analysis The Remicade Biosimilar market is analysed and market size information is provided by regions (countries). The key regions covered in the Remicade Biosimilar market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026. Competitive Landscape and Remicade Biosimilar Market Share Analysis Remicade Biosimilar market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Remicade Biosimilar business, the date to enter into the Remicade Biosimilar market, Remicade Biosimilar product introduction, recent developments, etc. The major vendors covered: Synthon Pharmaceuticals LG Life Sciences Novartis (Sandoz) Celltrion Biocon Hospira Merck Serono (Merck Group) Biogen idec Inc. Genentech (Roche Group)
1 Study Coverage 1.1 Remicade Biosimilar Product Introduction 1.2 Market Segments 1.3 Key Remicade Biosimilar Manufacturers Covered: Ranking by Revenue 1.4 Market by Type 1.4.1 Global Remicade Biosimilar Market Size Growth Rate by Type 1.4.2 100mg/10ml 1.4.3 500mg/50ml 1.5 Market by Application 1.5.1 Global Remicade Biosimilar Market Size Growth Rate by Application 1.5.2 Blood Disorders 1.5.3 Oncology Diseases 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Remicade Biosimilar Market Size, Estimates and Forecasts 2.1.1 Global Remicade Biosimilar Revenue 2015-2026 2.1.2 Global Remicade Biosimilar Sales 2015-2026 2.2 Global Remicade Biosimilar, Market Size by Producing Regions: 2015 VS 2020 VS 2026 2.2.1 Global Remicade Biosimilar Retrospective Market Scenario in Sales by Region: 2015-2020 2.2.2 Global Remicade Biosimilar Retrospective Market Scenario in Revenue by Region: 2015-2020 3 Global Remicade Biosimilar Competitor Landscape by Players 3.1 Remicade Biosimilar Sales by Manufacturers 3.1.1 Remicade Biosimilar Sales by Manufacturers (2015-2020) 3.1.2 Remicade Biosimilar Sales Market Share by Manufacturers (2015-2020) 3.2 Remicade Biosimilar Revenue by Manufacturers 3.2.1 Remicade Biosimilar Revenue by Manufacturers (2015-2020) 3.2.2 Remicade Biosimilar Revenue Share by Manufacturers (2015-2020) 3.2.3 Global Remicade Biosimilar Market Concentration Ratio (CR5 and HHI) (2015-2020) 3.2.4 Global Top 10 and Top 5 Companies by Remicade Biosimilar Revenue in 2019 3.2.5 Global Remicade Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Remicade Biosimilar Price by Manufacturers 3.4 Remicade Biosimilar Manufacturing Base Distribution, Product Types 3.4.1 Remicade Biosimilar Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Remicade Biosimilar Product Type 3.4.3 Date of International Manufacturers Enter into Remicade Biosimilar Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Market Size by Type (2015-2026) 4.1 Global Remicade Biosimilar Market Size by Type (2015-2020) 4.1.1 Global Remicade Biosimilar Sales by Type (2015-2020) 4.1.2 Global Remicade Biosimilar Revenue by Type (2015-2020) 4.1.3 Remicade Biosimilar Average Selling Price (ASP) by Type (2015-2026) 4.2 Global Remicade Biosimilar Market Size Forecast by Type (2021-2026) 4.2.1 Global Remicade Biosimilar Sales Forecast by Type (2021-2026) 4.2.2 Global Remicade Biosimilar Revenue Forecast by Type (2021-2026) 4.2.3 Remicade Biosimilar Average Selling Price (ASP) Forecast by Type (2021-2026) 4.3 Global Remicade Biosimilar Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Market Size by Application (2015-2026) 5.1 Global Remicade Biosimilar Market Size by Application (2015-2020) 5.1.1 Global Remicade Biosimilar Sales by Application (2015-2020) 5.1.2 Global Remicade Biosimilar Revenue by Application (2015-2020) 5.1.3 Remicade Biosimilar Price by Application (2015-2020) 5.2 Remicade Biosimilar Market Size Forecast by Application (2021-2026) 5.2.1 Global Remicade Biosimilar Sales Forecast by Application (2021-2026) 5.2.2 Global Remicade Biosimilar Revenue Forecast by Application (2021-2026) 5.2.3 Global Remicade Biosimilar Price Forecast by Application (2021-2026) 6 North America 6.1 North America Remicade Biosimilar by Country 6.1.1 North America Remicade Biosimilar Sales by Country 6.1.2 North America Remicade Biosimilar Revenue by Country 6.1.3 U.S. 6.1.4 Canada 6.2 North America Remicade Biosimilar Market Facts & Figures by Type 6.3 North America Remicade Biosimilar Market Facts & Figures by Application 7 Europe 7.1 Europe Remicade Biosimilar by Country 7.1.1 Europe Remicade Biosimilar Sales by Country 7.1.2 Europe Remicade Biosimilar Revenue by Country 7.1.3 Germany 7.1.4 France 7.1.5 U.K. 7.1.6 Italy 7.1.7 Russia 7.2 Europe Remicade Biosimilar Market Facts & Figures by Type 7.3 Europe Remicade Biosimilar Market Facts & Figures by Application 8 Asia Pacific 8.1 Asia Pacific Remicade Biosimilar by Region 8.1.1 Asia Pacific Remicade Biosimilar Sales by Region 8.1.2 Asia Pacific Remicade Biosimilar Revenue by Region 8.1.3 China 8.1.4 Japan 8.1.5 South Korea 8.1.6 India 8.1.7 Australia 8.1.8 Taiwan 8.1.9 Indonesia 8.1.10 Thailand 8.1.11 Malaysia 8.1.12 Philippines 8.1.13 Vietnam 8.2 Asia Pacific Remicade Biosimilar Market Facts & Figures by Type 8.3 Asia Pacific Remicade Biosimilar Market Facts & Figures by Application 9 Latin America 9.1 Latin America Remicade Biosimilar by Country 9.1.1 Latin America Remicade Biosimilar Sales by Country 9.1.2 Latin America Remicade Biosimilar Revenue by Country 9.1.3 Mexico 9.1.4 Brazil 9.1.5 Argentina 9.2 Central & South America Remicade Biosimilar Market Facts & Figures by Type 9.3 Central & South America Remicade Biosimilar Market Facts & Figures by Application 10 Middle East and Africa 10.1 Middle East and Africa Remicade Biosimilar by Country 10.1.1 Middle East and Africa Remicade Biosimilar Sales by Country 10.1.2 Middle East and Africa Remicade Biosimilar Revenue by Country 10.1.3 Turkey 10.1.4 Saudi Arabia 10.1.5 U.A.E 10.2 Middle East and Africa Remicade Biosimilar Market Facts & Figures by Type 10.3 Middle East and Africa Remicade Biosimilar Market Facts & Figures by Application 11 Company Profiles 11.1 Synthon Pharmaceuticals 11.1.1 Synthon Pharmaceuticals Corporation Information 11.1.2 Synthon Pharmaceuticals Description and Business Overview 11.1.3 Synthon Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020) 11.1.4 Synthon Pharmaceuticals Remicade Biosimilar Products Offered 11.1.5 Synthon Pharmaceuticals Related Developments 11.2 LG Life Sciences 11.2.1 LG Life Sciences Corporation Information 11.2.2 LG Life Sciences Description and Business Overview 11.2.3 LG Life Sciences Sales, Revenue and Gross Margin (2015-2020) 11.2.4 LG Life Sciences Remicade Biosimilar Products Offered 11.2.5 LG Life Sciences Related Developments 11.3 Novartis (Sandoz) 11.3.1 Novartis (Sandoz) Corporation Information 11.3.2 Novartis (Sandoz) Description and Business Overview 11.3.3 Novartis (Sandoz) Sales, Revenue and Gross Margin (2015-2020) 11.3.4 Novartis (Sandoz) Remicade Biosimilar Products Offered 11.3.5 Novartis (Sandoz) Related Developments 11.4 Celltrion 11.4.1 Celltrion Corporation Information 11.4.2 Celltrion Description and Business Overview 11.4.3 Celltrion Sales, Revenue and Gross Margin (2015-2020) 11.4.4 Celltrion Remicade Biosimilar Products Offered 11.4.5 Celltrion Related Developments 11.5 Biocon 11.5.1 Biocon Corporation Information 11.5.2 Biocon Description and Business Overview 11.5.3 Biocon Sales, Revenue and Gross Margin (2015-2020) 11.5.4 Biocon Remicade Biosimilar Products Offered 11.5.5 Biocon Related Developments 11.6 Hospira 11.6.1 Hospira Corporation Information 11.6.2 Hospira Description and Business Overview 11.6.3 Hospira Sales, Revenue and Gross Margin (2015-2020) 11.6.4 Hospira Remicade Biosimilar Products Offered 11.6.5 Hospira Related Developments 11.7 Merck Serono (Merck Group) 11.7.1 Merck Serono (Merck Group) Corporation Information 11.7.2 Merck Serono (Merck Group) Description and Business Overview 11.7.3 Merck Serono (Merck Group) Sales, Revenue and Gross Margin (2015-2020) 11.7.4 Merck Serono (Merck Group) Remicade Biosimilar Products Offered 11.7.5 Merck Serono (Merck Group) Related Developments 11.8 Biogen idec Inc. 11.8.1 Biogen idec Inc. Corporation Information 11.8.2 Biogen idec Inc. Description and Business Overview 11.8.3 Biogen idec Inc. Sales, Revenue and Gross Margin (2015-2020) 11.8.4 Biogen idec Inc. Remicade Biosimilar Products Offered 11.8.5 Biogen idec Inc. Related Developments 11.9 Genentech (Roche Group) 11.9.1 Genentech (Roche Group) Corporation Information 11.9.2 Genentech (Roche Group) Description and Business Overview 11.9.3 Genentech (Roche Group) Sales, Revenue and Gross Margin (2015-2020) 11.9.4 Genentech (Roche Group) Remicade Biosimilar Products Offered 11.9.5 Genentech (Roche Group) Related Developments 11.1 Synthon Pharmaceuticals 11.1.1 Synthon Pharmaceuticals Corporation Information 11.1.2 Synthon Pharmaceuticals Description and Business Overview 11.1.3 Synthon Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020) 11.1.4 Synthon Pharmaceuticals Remicade Biosimilar Products Offered 11.1.5 Synthon Pharmaceuticals Related Developments 12 Future Forecast by Regions (Countries) (2021-2026) 12.1 Remicade Biosimilar Market Estimates and Projections by Region 12.1.1 Global Remicade Biosimilar Sales Forecast by Regions 2021-2026 12.1.2 Global Remicade Biosimilar Revenue Forecast by Regions 2021-2026 12.2 North America Remicade Biosimilar Market Size Forecast (2021-2026) 12.2.1 North America: Remicade Biosimilar Sales Forecast (2021-2026) 12.2.2 North America: Remicade Biosimilar Revenue Forecast (2021-2026) 12.2.3 North America: Remicade Biosimilar Market Size Forecast by Country (2021-2026) 12.3 Europe Remicade Biosimilar Market Size Forecast (2021-2026) 12.3.1 Europe: Remicade Biosimilar Sales Forecast (2021-2026) 12.3.2 Europe: Remicade Biosimilar Revenue Forecast (2021-2026) 12.3.3 Europe: Remicade Biosimilar Market Size Forecast by Country (2021-2026) 12.4 Asia Pacific Remicade Biosimilar Market Size Forecast (2021-2026) 12.4.1 Asia Pacific: Remicade Biosimilar Sales Forecast (2021-2026) 12.4.2 Asia Pacific: Remicade Biosimilar Revenue Forecast (2021-2026) 12.4.3 Asia Pacific: Remicade Biosimilar Market Size Forecast by Region (2021-2026) 12.5 Latin America Remicade Biosimilar Market Size Forecast (2021-2026) 12.5.1 Latin America: Remicade Biosimilar Sales Forecast (2021-2026) 12.5.2 Latin America: Remicade Biosimilar Revenue Forecast (2021-2026) 12.5.3 Latin America: Remicade Biosimilar Market Size Forecast by Country (2021-2026) 12.6 Middle East and Africa Remicade Biosimilar Market Size Forecast (2021-2026) 12.6.1 Middle East and Africa: Remicade Biosimilar Sales Forecast (2021-2026) 12.6.2 Middle East and Africa: Remicade Biosimilar Revenue Forecast (2021-2026) 12.6.3 Middle East and Africa: Remicade Biosimilar Market Size Forecast by Country (2021-2026) 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Porter's Five Forces Analysis 13.5 Primary Interviews with Key Remicade Biosimilar Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Remicade Biosimilar Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

Get Free Sample

List of Tables Table 1. Remicade Biosimilar Market Segments Table 2. Ranking of Global Top Remicade Biosimilar Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Remicade Biosimilar Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million) Table 4. Major Manufacturers of 100mg/10ml Table 5. Major Manufacturers of 500mg/50ml Table 6. Global Remicade Biosimilar Market Size Growth Rate by Application 2020-2026 (K MT) Table 7. Global Remicade Biosimilar Market Size by Region (K MT) & (US$ Million): 2020 VS 2026 Table 8. Global Remicade Biosimilar Sales by Regions 2015-2020 (K MT) Table 9. Global Remicade Biosimilar Sales Market Share by Regions (2015-2020) Table 10. Global Remicade Biosimilar Revenue by Regions 2015-2020 (US$ Million) Table 11. Global Remicade Biosimilar Sales by Manufacturers (2015-2020) (K MT) Table 12. Global Remicade Biosimilar Sales Share by Manufacturers (2015-2020) Table 13. Global Remicade Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 14. Global Remicade Biosimilar by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Remicade Biosimilar as of 2019) Table 15. Remicade Biosimilar Revenue by Manufacturers (2015-2020) (US$ Million) Table 16. Remicade Biosimilar Revenue Share by Manufacturers (2015-2020) Table 17. Key Manufacturers Remicade Biosimilar Price (2015-2020) (USD/MT) Table 18. Remicade Biosimilar Manufacturers Manufacturing Base Distribution and Headquarters Table 19. Manufacturers Remicade Biosimilar Product Type Table 20. Date of International Manufacturers Enter into Remicade Biosimilar Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Global Remicade Biosimilar Sales by Type (2015-2020) (K MT) Table 23. Global Remicade Biosimilar Sales Share by Type (2015-2020) Table 24. Global Remicade Biosimilar Revenue by Type (2015-2020) (US$ Million) Table 25. Global Remicade Biosimilar Revenue Share by Type (2015-2020) Table 26. Remicade Biosimilar Average Selling Price (ASP) by Type 2015-2020 (USD/MT) Table 27. Global Remicade Biosimilar Sales by Application (2015-2020) (K MT) Table 28. Global Remicade Biosimilar Sales Share by Application (2015-2020) Table 29. North America Remicade Biosimilar Sales by Country (2015-2020) (K MT) Table 30. North America Remicade Biosimilar Sales Market Share by Country (2015-2020) Table 31. North America Remicade Biosimilar Revenue by Country (2015-2020) (US$ Million) Table 32. North America Remicade Biosimilar Revenue Market Share by Country (2015-2020) Table 33. North America Remicade Biosimilar Sales by Type (2015-2020) (K MT) Table 34. North America Remicade Biosimilar Sales Market Share by Type (2015-2020) Table 35. North America Remicade Biosimilar Sales by Application (2015-2020) (K MT) Table 36. North America Remicade Biosimilar Sales Market Share by Application (2015-2020) Table 37. Europe Remicade Biosimilar Sales by Country (2015-2020) (K MT) Table 38. Europe Remicade Biosimilar Sales Market Share by Country (2015-2020) Table 39. Europe Remicade Biosimilar Revenue by Country (2015-2020) (US$ Million) Table 40. Europe Remicade Biosimilar Revenue Market Share by Country (2015-2020) Table 41. Europe Remicade Biosimilar Sales by Type (2015-2020) (K MT) Table 42. Europe Remicade Biosimilar Sales Market Share by Type (2015-2020) Table 43. Europe Remicade Biosimilar Sales by Application (2015-2020) (K MT) Table 44. Europe Remicade Biosimilar Sales Market Share by Application (2015-2020) Table 45. Asia Pacific Remicade Biosimilar Sales by Region (2015-2020) (K MT) Table 46. Asia Pacific Remicade Biosimilar Sales Market Share by Region (2015-2020) Table 47. Asia Pacific Remicade Biosimilar Revenue by Region (2015-2020) (US$ Million) Table 48. Asia Pacific Remicade Biosimilar Revenue Market Share by Region (2015-2020) Table 49. Asia Pacific Remicade Biosimilar Sales by Type (2015-2020) (K MT) Table 50. Asia Pacific Remicade Biosimilar Sales Market Share by Type (2015-2020) Table 51. Asia Pacific Remicade Biosimilar Sales by Application (2015-2020) (K MT) Table 52. Asia Pacific Remicade Biosimilar Sales Market Share by Application (2015-2020) Table 53. Latin America Remicade Biosimilar Sales by Country (2015-2020) (K MT) Table 54. Latin America Remicade Biosimilar Sales Market Share by Country (2015-2020) Table 55. Latin Americaa Remicade Biosimilar Revenue by Country (2015-2020) (US$ Million) Table 56. Latin America Remicade Biosimilar Revenue Market Share by Country (2015-2020) Table 57. Latin America Remicade Biosimilar Sales by Type (2015-2020) (K MT) Table 58. Latin America Remicade Biosimilar Sales Market Share by Type (2015-2020) Table 59. Latin America Remicade Biosimilar Sales by Application (2015-2020) (K MT) Table 60. Latin America Remicade Biosimilar Sales Market Share by Application (2015-2020) Table 61. Middle East and Africa Remicade Biosimilar Sales by Country (2015-2020) (K MT) Table 62. Middle East and Africa Remicade Biosimilar Sales Market Share by Country (2015-2020) Table 63. Middle East and Africa Remicade Biosimilar Revenue by Country (2015-2020) (US$ Million) Table 64. Middle East and Africa Remicade Biosimilar Revenue Market Share by Country (2015-2020) Table 65. Middle East and Africa Remicade Biosimilar Sales by Type (2015-2020) (K MT) Table 66. Middle East and Africa Remicade Biosimilar Sales Market Share by Type (2015-2020) Table 67. Middle East and Africa Remicade Biosimilar Sales by Application (2015-2020) (K MT) Table 68. Middle East and Africa Remicade Biosimilar Sales Market Share by Application (2015-2020) Table 69. Synthon Pharmaceuticals Corporation Information Table 70. Synthon Pharmaceuticals Description and Major Businesses Table 71. Synthon Pharmaceuticals Remicade Biosimilar Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 72. Synthon Pharmaceuticals Product Table 73. Synthon Pharmaceuticals Recent Development Table 74. LG Life Sciences Corporation Information Table 75. LG Life Sciences Description and Major Businesses Table 76. LG Life Sciences Remicade Biosimilar Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 77. LG Life Sciences Product Table 78. LG Life Sciences Recent Development Table 79. Novartis (Sandoz) Corporation Information Table 80. Novartis (Sandoz) Description and Major Businesses Table 81. Novartis (Sandoz) Remicade Biosimilar Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 82. Novartis (Sandoz) Product Table 83. Novartis (Sandoz) Recent Development Table 84. Celltrion Corporation Information Table 85. Celltrion Description and Major Businesses Table 86. Celltrion Remicade Biosimilar Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 87. Celltrion Product Table 88. Celltrion Recent Development Table 89. Biocon Corporation Information Table 90. Biocon Description and Major Businesses Table 91. Biocon Remicade Biosimilar Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 92. Biocon Product Table 93. Biocon Recent Development Table 94. Hospira Corporation Information Table 95. Hospira Description and Major Businesses Table 96. Hospira Remicade Biosimilar Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 97. Hospira Product Table 98. Hospira Recent Development Table 99. Merck Serono (Merck Group) Corporation Information Table 100. Merck Serono (Merck Group) Description and Major Businesses Table 101. Merck Serono (Merck Group) Remicade Biosimilar Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 102. Merck Serono (Merck Group) Product Table 103. Merck Serono (Merck Group) Recent Development Table 104. Biogen idec Inc. Corporation Information Table 105. Biogen idec Inc. Description and Major Businesses Table 106. Biogen idec Inc. Remicade Biosimilar Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 107. Biogen idec Inc. Product Table 108. Biogen idec Inc. Recent Development Table 109. Genentech (Roche Group) Corporation Information Table 110. Genentech (Roche Group) Description and Major Businesses Table 111. Genentech (Roche Group) Remicade Biosimilar Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 112. Genentech (Roche Group) Product Table 113. Genentech (Roche Group) Recent Development Table 114. Global Remicade Biosimilar Sales Forecast by Regions (2021-2026) (K MT) Table 115. Global Remicade Biosimilar Sales Market Share Forecast by Regions (2021-2026) Table 116. Global Remicade Biosimilar Revenue Forecast by Regions (2021-2026) (US$ Million) Table 117. Global Remicade Biosimilar Revenue Market Share Forecast by Regions (2021-2026) Table 118. North America: Remicade Biosimilar Sales Forecast by Country (2021-2026) (K MT) Table 119. North America: Remicade Biosimilar Revenue Forecast by Country (2021-2026) (US$ Million) Table 120. Europe: Remicade Biosimilar Sales Forecast by Country (2021-2026) (K MT) Table 121. Europe: Remicade Biosimilar Revenue Forecast by Country (2021-2026) (US$ Million) Table 122. Asia Pacific: Remicade Biosimilar Sales Forecast by Region (2021-2026) (K MT) Table 123. Asia Pacific: Remicade Biosimilar Revenue Forecast by Region (2021-2026) (US$ Million) Table 124. Latin America: Remicade Biosimilar Sales Forecast by Country (2021-2026) (K MT) Table 125. Latin America: Remicade Biosimilar Revenue Forecast by Country (2021-2026) (US$ Million) Table 126. Middle East and Africa: Remicade Biosimilar Sales Forecast by Country (2021-2026) (K MT) Table 127. Middle East and Africa: Remicade Biosimilar Revenue Forecast by Country (2021-2026) (US$ Million) Table 128. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 129. Key Challenges Table 130. Market Risks Table 131. Main Points Interviewed from Key Remicade Biosimilar Players Table 132. Remicade Biosimilar Customers List Table 133. Remicade Biosimilar Distributors List Table 134. Research Programs/Design for This Report Table 135. Key Data Information from Secondary Sources Table 136. Key Data Information from Primary Sources List of Figures Figure 1. Remicade Biosimilar Product Picture Figure 2. Global Remicade Biosimilar Sales Market Share by Type in 2020 & 2026 Figure 3. 100mg/10ml Product Picture Figure 4. 500mg/50ml Product Picture Figure 5. Global Remicade Biosimilar Sales Market Share by Application in 2020 & 2026 Figure 6. Blood Disorders Figure 7. Oncology Diseases Figure 8. Remicade Biosimilar Report Years Considered Figure 9. Global Remicade Biosimilar Market Size 2015-2026 (US$ Million) Figure 10. Global Remicade Biosimilar Sales 2015-2026 (K MT) Figure 11. Global Remicade Biosimilar Market Size Market Share by Region: 2020 Versus 2026 Figure 12. Global Remicade Biosimilar Sales Market Share by Region (2015-2020) Figure 13. Global Remicade Biosimilar Sales Market Share by Region in 2019 Figure 14. Global Remicade Biosimilar Revenue Market Share by Region (2015-2020) Figure 15. Global Remicade Biosimilar Revenue Market Share by Region in 2019 Figure 16. Global Remicade Biosimilar Sales Share by Manufacturer in 2019 Figure 17. The Top 10 and 5 Players Market Share by Remicade Biosimilar Revenue in 2019 Figure 18. Remicade Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 19. Global Remicade Biosimilar Sales Market Share by Type (2015-2020) Figure 20. Global Remicade Biosimilar Sales Market Share by Type in 2019 Figure 21. Global Remicade Biosimilar Revenue Market Share by Type (2015-2020) Figure 22. Global Remicade Biosimilar Revenue Market Share by Type in 2019 Figure 23. Global Remicade Biosimilar Market Share by Price Range (2015-2020) Figure 24. Global Remicade Biosimilar Sales Market Share by Application (2015-2020) Figure 25. Global Remicade Biosimilar Sales Market Share by Application in 2019 Figure 26. Global Remicade Biosimilar Revenue Market Share by Application (2015-2020) Figure 27. Global Remicade Biosimilar Revenue Market Share by Application in 2019 Figure 28. North America Remicade Biosimilar Sales Growth Rate 2015-2020 (K MT) Figure 29. North America Remicade Biosimilar Revenue Growth Rate 2015-2020 (US$ Million) Figure 30. North America Remicade Biosimilar Sales Market Share by Country in 2019 Figure 31. North America Remicade Biosimilar Revenue Market Share by Country in 2019 Figure 32. U.S. Remicade Biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 33. U.S. Remicade Biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 34. Canada Remicade Biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 35. Canada Remicade Biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 36. North America Remicade Biosimilar Market Share by Type in 2019 Figure 37. North America Remicade Biosimilar Market Share by Application in 2019 Figure 38. Europe Remicade Biosimilar Sales Growth Rate 2015-2020 (K MT) Figure 39. Europe Remicade Biosimilar Revenue Growth Rate 2015-2020 (US$ Million) Figure 40. Europe Remicade Biosimilar Sales Market Share by Country in 2019 Figure 41. Europe Remicade Biosimilar Revenue Market Share by Country in 2019 Figure 42. Germany Remicade Biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 43. Germany Remicade Biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 44. France Remicade Biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 45. France Remicade Biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 46. U.K. Remicade Biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 47. U.K. Remicade Biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 48. Italy Remicade Biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 49. Italy Remicade Biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 50. Russia Remicade Biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 51. Russia Remicade Biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 52. Europe Remicade Biosimilar Market Share by Type in 2019 Figure 53. Europe Remicade Biosimilar Market Share by Application in 2019 Figure 54. Asia Pacific Remicade Biosimilar Sales Growth Rate 2015-2020 (K MT) Figure 55. Asia Pacific Remicade Biosimilar Revenue Growth Rate 2015-2020 (US$ Million) Figure 56. Asia Pacific Remicade Biosimilar Sales Market Share by Region in 2019 Figure 57. Asia Pacific Remicade Biosimilar Revenue Market Share by Region in 2019 Figure 58. China Remicade Biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 59. China Remicade Biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 60. Japan Remicade Biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 61. Japan Remicade Biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 62. South Korea Remicade Biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 63. South Korea Remicade Biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 64. India Remicade Biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 65. India Remicade Biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 66. Australia Remicade Biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 67. Australia Remicade Biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 68. Taiwan Remicade Biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 69. Taiwan Remicade Biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. Indonesia Remicade Biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 71. Indonesia Remicade Biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 72. Thailand Remicade Biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 73. Thailand Remicade Biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 74. Malaysia Remicade Biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 75. Malaysia Remicade Biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 76. Philippines Remicade Biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 77. Philippines Remicade Biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. Vietnam Remicade Biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 79. Vietnam Remicade Biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 80. Asia Pacific Remicade Biosimilar Market Share by Type in 2019 Figure 81. Asia Pacific Remicade Biosimilar Market Share by Application in 2019 Figure 82. Latin America Remicade Biosimilar Sales Growth Rate 2015-2020 (K MT) Figure 83. Latin America Remicade Biosimilar Revenue Growth Rate 2015-2020 (US$ Million) Figure 84. Latin America Remicade Biosimilar Sales Market Share by Country in 2019 Figure 85. Latin America Remicade Biosimilar Revenue Market Share by Country in 2019 Figure 86. Mexico Remicade Biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 87. Mexico Remicade Biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 88. Brazil Remicade Biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 89. Brazil Remicade Biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 90. Argentina Remicade Biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 91. Argentina Remicade Biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 92. Latin America Remicade Biosimilar Market Share by Type in 2019 Figure 93. Latin America Remicade Biosimilar Market Share by Application in 2019 Figure 94. Middle East and Africa Remicade Biosimilar Sales Growth Rate 2015-2020 (K MT) Figure 95. Middle East and Africa Remicade Biosimilar Revenue Growth Rate 2015-2020 (US$ Million) Figure 96. Middle East and Africa Remicade Biosimilar Sales Market Share by Country in 2019 Figure 97. Middle East and Africa Remicade Biosimilar Revenue Market Share by Country in 2019 Figure 98. Turkey Remicade Biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 99. Turkey Remicade Biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 100. Saudi Arabia Remicade Biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 101. Saudi Arabia Remicade Biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 102. U.A.E Remicade Biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 103. U.A.E Remicade Biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 104. Middle East and Africa Remicade Biosimilar Market Share by Type in 2019 Figure 105. Middle East and Africa Remicade Biosimilar Market Share by Application in 2019 Figure 106. North America Remicade Biosimilar Sales Growth Rate Forecast (2021-2026) (K MT) Figure 107. North America Remicade Biosimilar Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 108. Europe Remicade Biosimilar Sales Growth Rate Forecast (2021-2026) (K MT) Figure 109. Europe Remicade Biosimilar Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 110. Asia Pacific Remicade Biosimilar Sales Growth Rate Forecast (2021-2026) (K MT) Figure 111. Asia Pacific Remicade Biosimilar Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 112. Latin America Remicade Biosimilar Sales Growth Rate Forecast (2021-2026) (K MT) Figure 113. Latin America Remicade Biosimilar Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 114. Middle East and Africa Remicade Biosimilar Sales Growth Rate Forecast (2021-2026) (K MT) Figure 115. Middle East and Africa Remicade Biosimilar Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 116. Porter's Five Forces Analysis Figure 117. Channels of Distribution Figure 118. Distributors Profiles Figure 119. Bottom-up and Top-down Approaches for This Report Figure 120. Data Triangulation Figure 121. Key Executives Interviewed

Get Free Sample

Related Reports

Global Remicade Biosimilar Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Cushing's Syndrome Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most ...
read more

Global Remicade Biosimilar Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Tyrosine Kinase Inhibitors Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Tyrosine kinase inhibitors are small molecules that bind to the receptor site of the kinase enzyme available at cell surface. Scope of the Report: The global tyrosine kinase inhibitors market is e ...
read more

Global Remicade Biosimilar Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global 2D Chromatography Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

2D chromatography is a type of chromatographic technique in which the injected sample is separated by passing through two different separation stages. This is done by injecting the eluent from the fir ...
read more

Global Remicade Biosimilar Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Astringent Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Astringent are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure. Scope of the Report: In 2018, North America is expected to account for th ...
read more

Global Remicade Biosimilar Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Disintegrants Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Disintegrants are agents added to tablet (and some encapsulated) formulations to promote the breakup of the tablet (and capsule “slugs') into smaller fragments in an aqueous environment thereby ...
read more


Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.


Cards For Payment

Why Choose us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
-Marketing Manager at a pharma company in Belgium

How To Reach Us

Reach out to our most senior Sales Professional-
Jay Matthews

+1 513 549 5911 (U.S.),
    +44 203 318 2846 (U.K.)
sales@marketresearchvision.com
 

Our Clients






Market Research Vision

About Us


Market Research Vision is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports. Serving as a market research firm, we help our clients in finding: what’s next? We believe in finding creative and innovative solutions through customized and syndicated research reports.
Read More


Contact Us


 
sales@marketresearchvision.com


+1 513 549 5911 (U.S.)
+44 203 318 2846 (U.K.)